Marker Therapeutics (MRKR) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.53
-0.39
-0.26
-0.12

Details

Expected EPS
-0.190767
Actual EPS
N/A
Surprise EPS
0.19
Surprise Percent
+100%

Description

Marker Therapeutics (MRKR) will report earnings of for Q1 2026 on March 12, 2026.

0 Comments

Share your thoughts